VeinWay
Or Yehuda, Israel· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
VeinWay creates a first‑of‑its‑kind catheter to quickly cross chronic venous occlusions, addressing an unmet need in vascular medicine.
VascularVenous Disease
Technology Platform
A nitinol‑based catheter system (Traversa) that uses a proprietary crossing tip and torque control to navigate and recanalize chronic venous occlusions quickly and safely.
Opportunities
A clear unmet need for reliable crossing of chronic venous occlusions creates a large market for a device that can reduce procedure time and improve patency rates.
Risk Factors
Regulatory approval and demonstration of clinical superiority over existing guidewires are critical; adoption may be slowed by physician familiarity with entrenched technologies.
Competitive Landscape
Current competitors include Medtronic, Boston Scientific, and Philips, which offer conventional guidewires and atherectomy tools; VeinWay differentiates itself with a dedicated crossing catheter designed for previously uncrossable veins.